Here, we developed novel GEMMs of human B-ALL through transgenic overexpression of Crlf2 and concomitant expression of mutant Jak2 to determine the role of mutant JAK2 in leukemia initiation and maintenance of disease. The gene discussed is CRLF2; the disease is leukemia.